These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 2472085)

  • 1. In vitro studies of the interaction of heparin, low molecular weight heparin and heparinoids with platelets.
    Messmore HL; Griffin B; Fareed J; Coyne E; Seghatchian J
    Ann N Y Acad Sci; 1989; 556():217-32. PubMed ID: 2472085
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction of heparinoids with platelets: comparison with heparin and low molecular weight heparins.
    Messmore HL; Griffin B; Koza M; Seghatchian J; Fareed J; Coyne E
    Semin Thromb Hemost; 1991; 17 Suppl 1():57-9. PubMed ID: 1712512
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Platelet aggregation in humans and nonhuman primates: relevance to xenotransplantation.
    Iwase H; Ekser B; Zhou H; Dons EM; Cooper DK; Ezzelarab MB
    Xenotransplantation; 2012; 19(4):233-43. PubMed ID: 22909136
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of heparin and heparinoids on platelet aggregation.
    Cepelák V; Roubal Z; Zemanová I; Opatrný K
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1984; 111(6):750-60. PubMed ID: 6083950
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low molecular weight heparin as an anticoagulant for in vitro platelet function studies.
    van Wyk V; Heyns AD
    Thromb Res; 1990 Feb; 57(4):601-9. PubMed ID: 2158153
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The platelet proaggregating and potentiating effects of unfractionated heparin, low molecular weight heparin and heparinoid in intensive care patients and healthy controls.
    Burgess JK; Chong BH
    Eur J Haematol; 1997 Apr; 58(4):279-85. PubMed ID: 9186540
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effect of heparin on platelet aggregation in vitro].
    Róka L; Isert D
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1984; 111(6):735-49. PubMed ID: 6083949
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Parnaparin, a low-molecular-weight heparin, prevents P-selectin-dependent formation of platelet-leukocyte aggregates in human whole blood.
    Maugeri N; Di Fabio G; Barbanti M; de Gaetano G; Donati MB; Cerletti C
    Thromb Haemost; 2007 Jun; 97(6):965-73. PubMed ID: 17549299
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of heparin on platelet monolayer adhesion, aggregation and production of malondialdehyde.
    Davies JA; Menys VC
    Thromb Res; 1982 Apr; 26(1):31-41. PubMed ID: 7101245
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of unfractionated and low molecular weight heparin on platelet-induced thrombin formation time and platelet adhesion.
    Basic-Micic M; Breddin HK
    Semin Thromb Hemost; 1993; 19 Suppl 1():22-8. PubMed ID: 8395725
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Defective ristocetin-induced platelet aggregation in von Willebrand's disease and its correction by factor VIII.
    Weiss HJ; Rogers J; Brand H
    J Clin Invest; 1973 Nov; 52(11):2697-707. PubMed ID: 4201262
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of ex vivo anticoagulants on whole blood platelet aggregation.
    Kalb ML; Potura L; Scharbert G; Kozek-Langenecker SA
    Platelets; 2009 Feb; 20(1):7-11. PubMed ID: 19172515
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Electrokinetic phenomena and platelet aggregation. I. Electrokinetic studies.
    Stolz JF; Migne J; Alexandre P; Santonja R; Streiff F; Larcan A
    Acta Univ Carol Med Monogr; 1972; 53():53-7. PubMed ID: 4133935
    [No Abstract]   [Full Text] [Related]  

  • 14. Adhesion of platelets to purified solid-phase von Willebrand factor: effects of wall shear rate, ADP, thrombin, and ristocetin.
    Olson JD; Zaleski A; Herrmann D; Flood PA
    J Lab Clin Med; 1989 Jul; 114(1):6-18. PubMed ID: 2786916
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Studies investigating platelet aggregation and release initiated by sera from patients with thrombotic thrombocytopenic purpura.
    Kelton JG; Moore JC; Murphy WG
    Blood; 1987 Mar; 69(3):924-8. PubMed ID: 3493046
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unexpected effects of aurin tricarboxylic acid on human platelets.
    Kinlough-Rathbone RL; Packham MA
    Thromb Haemost; 1992 Aug; 68(2):189-93. PubMed ID: 1412166
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thrombin regulation of platelet interaction with damaged vessel wall and isolated collagen type I at arterial flow conditions in a porcine model: effects of hirudins, heparin, and calcium chelation.
    Badimon L; Badimon JJ; Lassila R; Heras M; Chesebro JH; Fuster V
    Blood; 1991 Jul; 78(2):423-34. PubMed ID: 2070078
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of coagulation and platelet adhesion to extracellular matrix by unfractionated heparin and a low molecular weight heparin.
    Krupinski K; Basic-Micic M; Lindhoff E; Breddin HK
    Blut; 1990 Nov; 61(5):289-94. PubMed ID: 2176900
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The parasitic hematophagous worm Haemonchus contortus inhibits human platelet aggregation and adhesion: partial purification of a platelet inhibitor.
    Crab A; Noppe W; Pelicaen C; Van Hoorelbeke K; Deckmyn H
    Thromb Haemost; 2002 May; 87(5):899-904. PubMed ID: 12038795
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro effects of aprosulate sodium, a novel anticoagulant, on platelet activation: possible mechanism for antiplatelet action.
    Sugidachi A; Breiter N; Ogawa T; Asai F; Koike H
    Thromb Haemost; 1996 Nov; 76(5):786-90. PubMed ID: 8950791
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.